drugset / Trial / NCT07669207

Extended Azithromycin Treatment in Prelabor Rupture of Membranes

NCT07669207

Phase 4 Not yet recruiting 30 enrolled Alexa Henderson
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to learn whether adding extra doses of azithromycin to the standard antibiotic treatment for preterm prelabor rupture of membranes may improve pregnancy outcomes for patients between 22 weeks and 28 weeks gestational age. Researchers will compare the standard antibiotic treatment to the standard antibiotic treatment with additional doses of azithromycin. Participants will: * Be randomly assigned to one of two groups: * The standard antibiotic treatment * The standard antibiotic treatment plus 7 additional doses of oral azithromycin 500 mg every other day. * Participants will be asked to complete a survey regarding their experience and side effects.

Timeline

Start
2026-07-01
Primary completion
2028-05
Completion
2028-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 500 mg Oral
Subject Azithromycin Small molecule 1000 mg Oral